Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

New Frontier Health : to Announce Fourth Quarter and Fiscal Year 2020 Financial Results on April 8, 2021

03/31/2021 | 07:31am EST

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that it plans to release its fourth quarter and fiscal year ended December 31, 2020, financial results before the U.S. market opens on Thursday, April 8, 2021.

The Company will hold a conference call on Thursday, April 8, 2021, at 8:00 am Eastern Time (or Thursday, April 8, 2021, at 8:00 pm Beijing Time) to discuss the financial results. Participants may access the call by dialing the following numbers:

United States: 1-877-407-0789
International: 1-201-689-8562
China Domestic: 86 400 120 2840
Hong Kong: 800 965 561
Conference ID: 13718229

Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volume.
The replay will be accessible through April 15, 2021, by dialing the following numbers:

United States: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 13718229

A webcast will be available on the Company’s investor relations website at www.nfh.com.cn and will be archived on the site shortly after the call has concluded. A presentation to accompany the call will also be available for download on the website.

About New Frontier Health Corporation
New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals in operation or under construction in all four tier 1 cities and selected tier 2 cities. Additional information may be found at www.nfh.com.cn.


ę Business Wire 2021
All news about NEW FRONTIER HEALTH CORPORATION
01/11NEW FRONTIER HEALTH : Receives Notification from NYSE Regarding Delayed Filing of Semi-Ann..
PU
01/11New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filin..
BU
01/07NEW FRONTIER HEALTH : Announces Shareholders' Approval of Merger Agreement and Warranthold..
PU
01/07New Frontier Health Corporation Announces Shareholders' Approval of Merger Agreement an..
BU
2021Broncus to Invest $3 Million in Member of Consortium for New Frontier Health's Go-Priva..
MT
2021Broncus Enter into Strategic Partnership with New Frontier Health Corporation /United F..
CI
2021New Frontier Health Corporation announced that it expects to receive $3 million in fund..
CI
2021New Frontier Health Schedules Jan. 4 Shareholder Vote on Going-Private Transaction; Sto..
MT
2021NEW FRONTIER HEALTH : Announces Extraordinary General Meeting of Shareholders and Solicita..
PU
2021New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders..
BU
More news
Analyst Recommendations on NEW FRONTIER HEALTH CORPORATION
More recommendations
Financials
Sales 2021 2 930 M 461 M 461 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -150x
Yield 2021 -
Capitalization 9 314 M 1 466 M 1 466 M
Capi. / Sales 2021 3,18x
Capi. / Sales 2022 2,70x
Nbr of Employees 3 309
Free-Float -
Chart NEW FRONTIER HEALTH CORPORATION
Duration : Period :
New Frontier Health Corporation Technical Analysis Chart | NFH | KYG6461G1064 | MarketScreener
Technical analysis trends NEW FRONTIER HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 70,64 CNY
Average target price 76,51 CNY
Spread / Average Target 8,32%
EPS Revisions
Managers and Directors
Roberta Lipson Chief Executive Officer & Executive Director
Carl Wu President & Director
Walter Xue Chief Financial Officer
Kam Chung Leung Co-Chairman
Qi Yu Chen Co-Chairman